Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp, Baylor College MedicinefiledCriticalGenzyme Corp
Publication of AR095700A1publicationCriticalpatent/AR095700A1/es
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Métodos para el tratamiento y mejora de los síntomas de la osteogénesis imperfecta (OI) en un sujeto, administrando al sujeto una cantidad terapéuticamente eficaz de un agente de unión que se une al factor de crecimiento transformante b (TGFb).
ARP140101312A2013-03-202014-03-20Métodos para el tratamiento de la osteogénesis imperfecta
AR095700A1
(es)